![A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome | SpringerLink A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs11255-021-02860-4/MediaObjects/11255_2021_2860_Fig1_HTML.png)
A prospective cohort study of rituximab in the treatment of refractory nephrotic syndrome | SpringerLink
![Long-term Effectiveness of Ultra-Low Doses of Rituximab in Rheumatoid Arthritis - ACR Meeting Abstracts Long-term Effectiveness of Ultra-Low Doses of Rituximab in Rheumatoid Arthritis - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2021/09/ACR_1058093_3.gif)
Long-term Effectiveness of Ultra-Low Doses of Rituximab in Rheumatoid Arthritis - ACR Meeting Abstracts
![JCM | Free Full-Text | Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study | HTML JCM | Free Full-Text | Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study | HTML](https://www.mdpi.com/jcm/jcm-10-04941/article_deploy/html/images/jcm-10-04941-g001.png)
JCM | Free Full-Text | Off-Label Use of Rituximab in Patients with Different Types of Nephropathies in a Tertiary Hospital: A Retrospective Study | HTML
![AB0213 SAVING GLUCOCORTICOIDS AFTER RITUXIMAB TREATMENT IN PATIENTS WITH REUMATOID ARTHRITIS. ANALYSIS OF A COMMON CLINICAL PRACTICE COHORT | Annals of the Rheumatic Diseases AB0213 SAVING GLUCOCORTICOIDS AFTER RITUXIMAB TREATMENT IN PATIENTS WITH REUMATOID ARTHRITIS. ANALYSIS OF A COMMON CLINICAL PRACTICE COHORT | Annals of the Rheumatic Diseases](https://ard.bmj.com/content/annrheumdis/80/Suppl_1/1132.3/F1.large.jpg)
AB0213 SAVING GLUCOCORTICOIDS AFTER RITUXIMAB TREATMENT IN PATIENTS WITH REUMATOID ARTHRITIS. ANALYSIS OF A COMMON CLINICAL PRACTICE COHORT | Annals of the Rheumatic Diseases
![MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription - eBioMedicine MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription - eBioMedicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/54d3f666-b588-436f-a7e4-79c1145c3415/gr1.jpg)
MYC predetermines the sensitivity of gastrointestinal cancer to antifolate drugs through regulating TYMS transcription - eBioMedicine
![Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression - ScienceDirect Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0049017220302201-gr1.jpg)
Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression - ScienceDirect
![Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation - European Urology Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/86fdf621-8a13-47ae-ae8d-4a9692a87a76/gr1_lrg.jpg)
Effect of Intravesical Resiniferatoxin (RTX) on Lower Urinary Tract Symptoms, Urodynamic Parameters, and Quality of Life of Patients with Urodynamic Increased Bladder Sensation - European Urology
![Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12969-021-00627-w/MediaObjects/12969_2021_627_Fig5_HTML.png)
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text
![Frontiers | Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo | Microbiology Frontiers | Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo | Microbiology](https://www.frontiersin.org/files/Articles/645500/fmicb-12-645500-HTML/image_m/fmicb-12-645500-g001.jpg)
Frontiers | Lactobacillus reuteri Alleviates Gastrointestinal Toxicity of Rituximab by Regulating the Proinflammatory T Cells in vivo | Microbiology
![Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12969-021-00627-w/MediaObjects/12969_2021_627_Fig6_HTML.png)
Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE | Pediatric Rheumatology | Full Text
![JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review | HTML JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review | HTML](https://www.mdpi.com/jcm/jcm-09-03070/article_deploy/html/images/jcm-09-03070-g001.png)
JCM | Free Full-Text | Rituximab in the Treatment of Interstitial Lung Disease Associated with Autoimmune Diseases: Experience from a Single Referral Center and Literature Review | HTML
![Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect Effect of low-dose rituximab treatment on T- and B-cell lymphocyte imbalance in refractory myasthenia gravis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0165572819300645-ga1.jpg)